Director, Clinical Pharmacology

Lead the clinical pharmacology and pharmacometrics strategy across a portfolio of oncology and rare disease programs, acting as the Clinical Pharmacology lead for program development, regulatory interactions, and dose-exposure-safety modeling. Design and oversee Phase 1-3 studies, contribute to regulatory submissions (IB, INDs, NDAs), perform PK/PK-PD analyses and modeling (non-compartmental, population PK, PK-PD) using WinNonlin, NONMEM, Monolix, R, and related tools, and collaborate with cross-functional teams to accelerate development while ensuring regulatory readiness. Remote-friendly with on-site expectations in major US locations; offices in Salt Lake City, NYC, London, and other hubs.